Nurtec ODT Dosage
Generic name: RIMEGEPANT SULFATE 75mg
Dosage form: tablet, orally disintegrating
Drug class: CGRP inhibitors
Medically reviewed by Drugs.com. Last updated on Apr 3, 2025.
Recommended Dosing for Acute Treatment of Migraine
The recommended dose of NURTEC ODT is 75 mg taken orally, as needed.
The maximum dose in a 24-hour period is 75 mg. The safety of using more than 18 doses in a 30-day period has not been established.
Recommended Dosing for Preventive Treatment of Episodic Migraine
The recommended dosage of NURTEC ODT is 75 mg taken orally every other day.
Administration Information
Instruct the patient on the following administration instructions:
- •
- Use dry hands when opening the blister pack.
- •
- Peel back the foil covering of one blister and gently remove the orally disintegrating tablet (ODT). Do not push the ODT through the foil.
- •
- As soon as the blister is opened, remove the ODT and place on the tongue; alternatively, the ODT may be placed under the tongue.
- •
- The ODT will disintegrate in saliva so that it can be swallowed without additional liquid.
- •
- Take the ODT immediately after opening the blister pack. Do not store the ODT outside the blister pack for future use.
Concomitant Administration with Strong or Moderate CYP3A4 Inhibitors
Avoid concomitant administration of NURTEC ODT with strong inhibitors of CYP3A4. Avoid another dose of NURTEC ODT within 48 hours when it is concomitantly administered with moderate inhibitors of CYP3A4.
Frequently asked questions
- How do Ubrelvy, Qulipta and Nurtec compare for migraines?
- What are the new drugs for the treatment of migraine?
- How fast and effective is Nurtec ODT for migraines?
- How often can you take Nurtec ODT?
- Does Nurtec ODT cause weight gain?
- When do you take Nurtec ODT and how is it taken?
- What is the mechanism of action for Nurtec ODT?
- Nurtec coupon: Do I qualify and how much can I save?
More about Nurtec ODT (rimegepant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (320)
- Drug images
- Side effects
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.